Prof. Dr. Emre Merdan Fayda

Medizinische Interessengebiete, die der Arzt im Profil der Einrichtung selbst angegeben hat. Quelle: livhospital.com.

Berufserfahrung

• BerufserfahrungLiv Hospital, Radyasyon Onkolojisilivhospital.com
• 2012İstanbul Üniversitesi, Onkoloji Enstitüsü, Doçent Doktorlivhospital.com
• 2010-2011Stereotaktik Radyoterapi, Torasik Onkoloji, University of North Carolina, NC, ABDlivhospital.com
• 2006-2009Kocaeli Üniversitesi, Radyasyon Onkolojisi Anabilim Dalı, Yardımcı Doçentlivhospital.com
• 2004-2005GATA Radyasyon Onkolojisi Anabilim Dalı, Uzman Doktor, Yedek Subaylivhospital.com
• 1999-2004İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dr.Ar.Gör.livhospital.com

• FachgebietRadioonkologielivhospital.comAus der Quelle
• EinrichtungLiv Hospital Uluslivhospital.comAus der Quelle
• Publikationen53 PublikationenOpenAlex, Profilseite auf livhospital.comAus der Quelle
• Letzte Synchronisierung4. November 2026 20:55https://www.livhospital.com/prof-dr-merdan-faydalivhospital.com

1. Clinical distuingishing characteristics and management of phyllodes tumors of the breast.

   Journal of Clinical Oncology, 2015

   DOI 10.1200/jco.2015.33.15_suppl.e12060 Quelle: OpenAlex

2. Nasopharyngeal carcinoma patients with new primaries.

   Journal of Clinical Oncology, 2014

   DOI 10.1200/jco.2014.32.15_suppl.6087 Quelle: OpenAlex

3. Turkkan G, Bilici N, Sertel H, Keskus Y, Alkaya S, Tavli B, Ozkirim M, Fayda M. Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy. Front Oncol. 2022 Aug 16;12:909402.

   Quelle: Profilseite auf livhospital.com

4. Fayda M. Having ypN0 may not be enough to abandon the postmastectomy radiotherapy (PMRT) in Her-2 positive patients. Radiotherapy&Oncology. Published:May 25, 2023. DOI:https://doi.org/10.1016/j.radonc.2023.109722

   Quelle: Profilseite auf livhospital.com

5. Tambas M, Tavli B, Bilici N, Dizman A, Sertel H, Fayda M. Computed Tomography-Guided Optimization of Needle Insertion for Combined Intracavitary/Interstitial Brachytherapy With Utrecht Applicator in Locally Advanced Cervical Cancer. Pract Radiat Oncol. 2021 Feb 5:S1879-8500(21)00043-6. doi: 10.1016/j.prro.2021.01.008. Epub ahead of print. PMID: 33556579.

   Quelle: Profilseite auf livhospital.com

6. Turkkan, G, Bilici N, Sertel H, Tavlı B, Özkırım M, Fayda M. Dosimetric Comparison of Volumetric Modulated Arc Therapy and Dynamic Conformal Arc Therapy in Three fraction Single-isocenter Stereotactic Radiosurgery for Multiple Brain Metastases. Turk J Oncol 2022;37(1):67–73

   Quelle: Profilseite auf livhospital.com

7. Fayda M, Isin M, Tambas M, Guveli M, Meral R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, Ozgur E, Gezer U. Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy? Tumor Biology, 2015, 19 October, DOI: 10.1007/s13277-015-4189-1.

   Quelle: Profilseite auf livhospital.com

8. Fayda M, Tambaş, M, Karanlık H. Is sentinel lymph node biopsy enough for axillary macrometastasis? Turkish Journal of Surgery, 2015, Vol 31(4), pp. 253-255.

   Quelle: Profilseite auf livhospital.com

9. Aydiner A, Sen F, Tambas M, Ciftci R, Eralp Y, Saip P, Karanlik H, Fayda M, Kucucuk S, Onder S, Yavuz E, Muslumanoglu M, Igci A.Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment. Medicine (Baltimore), 2015 Dec;94(52):e2341.

   Quelle: Profilseite auf livhospital.com

10. Karanlık H, Özgür İ, Şahin D, Fayda M, Önder S, Yavuz E. Intraoperative ultrasound reduces the need for re-excision in breast conserving surgery, World Journal of Surgical Oncology, 2015 Nov 24;13(1):321.

    Quelle: Profilseite auf livhospital.com